刚刚$益方生物-U(SH688382)$ 公布Session PO.CT02.02 - Phase II Clinical Trials 2/CT246 / 5 - Open-label, single-arm, multicenter, phase 2 trial of garsorasib in KRAS G12C-mutated non-small-cell lung cancer:网页链接Gar...